Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.
about
Identification of new epilepsy treatments: issues in preclinical methodologyMutations of EFHC1, linked to juvenile myoclonic epilepsy, disrupt radial and tangential migrations during brain developmentDlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.Genes and brain malformations associated with abnormal neuron positioningExcitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersGenetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental modelsBasic mechanisms of catastrophic epilepsy -- overview from animal modelsConditional Loss of Arx From the Developing Dorsal Telencephalon Results in Behavioral Phenotypes Resembling Mild Human ARX Mutations.Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studiesCommon transcriptional mechanisms for visual photoreceptor cell differentiation among PancrustaceansA toolbox for spatiotemporal analysis of voltage-sensitive dye imaging data in brain slicesArx is required for normal enteroendocrine cell development in mice and humansA triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairmentA model of symptomatic infantile spasms syndromeGeneration of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.Westward ho! Pioneering mouse models for x-linked infantile spasms syndrome.Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division.Arx is required for specification of the zona incerta and reticular nucleus of the thalamus.Mutations in ARX Result in Several Defects Involving GABAergic Neurons.Molecular genetics of neuronal migration disorders.Epilepsy genetics--past, present, and futureRegulation of histone H3K4 methylation in brain development and disease.Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice.Developing an animal model for infantile spasms: pathogenesis, problems and progress.Genotype-phenotype correlation in neuronal migration disorders and cortical dysplasias.NPAS1 represses the generation of specific subtypes of cortical interneuronsThe promise of an interneuron-based cell therapy for epilepsyDeletion of Dlx1 results in reduced glutamatergic input to hippocampal interneurons.GABAB receptors in maintenance of neocortical circuit function.Altered GABA signaling in early life epilepsies.Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disordersCarisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasmsHyper-excitability and epilepsy generated by chronic early-life stress.Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function.Genomic perspectives of transcriptional regulation in forebrain development.Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression.Epilepsy as a neurodevelopmental disorder.Developmental interneuron subtype deficits after targeted loss of ArxEstradiol does not affect spasms in the betamethasone-NMDA rat model of infantile spasms.
P2860
Q24289140-EA159493-7077-4F48-90A8-A58BE3D823E8Q24297551-5F51CBF9-D25D-4A62-8BB7-AD39E2E599BAQ24633275-8A6DA587-A4C7-498F-A776-E11AC7070665Q26779045-1A3165B3-2E17-4A22-9F0E-314F153ACA48Q26796321-377B84A5-860F-4516-B1CA-0C16B1BF903BQ26861471-A8AFE47F-9F95-4355-AA67-702C3BD63B1EQ26864346-6E1045AF-E41B-48A1-94FC-E2752BF51691Q27302983-9382E3CE-7E4E-448B-8F5D-DEBACF605D1DQ27308052-58F12AA8-CC58-4807-B919-D7B2630C91E4Q27314909-243467C4-C827-46E1-8E19-1D3E000D0C17Q27342953-AACD0918-D532-4745-8D1C-4A107546EF12Q28506459-3E04659C-0465-4934-B93F-700256535CF1Q30484137-AB497A35-D89D-47ED-BD5F-3EFC4B5D630DQ30493207-5B2E73D1-27C6-45BD-84BA-E7934D2B6F5EQ30671578-1E04C648-04AB-46F8-AE2D-557F11CDEE15Q33615938-30DC4D54-59BF-4210-BA7D-79FA4B8CECC9Q33641779-065067E9-1420-4DC5-9FE6-62654781BC2FQ33684166-E5D3B8F9-28DC-483D-93E9-E490D0425D02Q33738402-B889F9CD-4A0D-488B-B161-3281AE6EB26EQ33790169-9275FD35-F8EC-4DF4-8275-CE00089C29ABQ33817292-C8DE6841-EFBF-41A4-AC44-4A6FCF2E2C41Q34079415-8249E3BE-FFC8-441C-B2FF-BFCEA8B858FCQ34132179-22925AEA-3E7D-4067-8D5E-3942E8EA4552Q34192123-B9B8A83D-09A5-46AA-92CE-5FC1F49C7AC9Q34479643-C11CA85F-1DE1-4691-8759-8C494C46C644Q34644372-88565735-A0BB-489C-9855-C2D00D91010BQ34685588-48F93178-5503-4A78-9AB3-C9F656AA3372Q34980061-C93CC4B1-1FC0-4554-8FD8-E2F07DAC3231Q35073433-5193C27E-CEE3-45F7-8135-E49B48249EFEQ35147300-97652547-A82F-43E1-AEFC-41174AEDE5D4Q35173644-EF5B3F31-472B-4F88-88AE-38DDBE73B1CDQ35204540-3559CFFD-2703-417F-965D-29D0CCD48EB3Q35400199-5BD3237C-431D-467C-A43E-A99F073A5C1BQ35559133-0E01047E-758E-4F24-9522-6E8722185145Q35591685-C5040E31-5812-4057-9AAC-8D7F1C00854CQ35627595-E21E2C08-A022-4E91-81EA-D6E298B9CE01Q35750224-4A9A95E6-628F-47E1-A5C9-BB2A0828E850Q35838099-708D859D-85E1-4993-A36A-3360379275DCQ36048943-49D1557E-F082-489F-9FB5-E93B2AA90A25Q36058190-18469000-CE6E-4090-8D08-F5800D0BE103
P2860
Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Targeted loss of Arx results i ...... otype in heterozygous females.
@ast
Targeted loss of Arx results i ...... otype in heterozygous females.
@en
type
label
Targeted loss of Arx results i ...... otype in heterozygous females.
@ast
Targeted loss of Arx results i ...... otype in heterozygous females.
@en
prefLabel
Targeted loss of Arx results i ...... otype in heterozygous females.
@ast
Targeted loss of Arx results i ...... otype in heterozygous females.
@en
P2093
P2860
P356
P1433
P1476
Targeted loss of Arx results i ...... otype in heterozygous females.
@en
P2093
Amy Brooks-Kayal
Eric Marsh
Ernest Gomez
Grazia Mancini
Ilya Nasrallah
Jeffrey A Golden
Jeremy Minarcik
Jyotsna Sudi
Patricia Labosky
P2860
P304
P356
10.1093/BRAIN/AWP107
P407
P577
2009-05-12T00:00:00Z